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Abstract: Decreases in short-chain-fatty-acids (SCFAs) are linked to inflammatory bowel disease
(IBD). Yet, the mechanisms through which SCFAs promote wound healing, orchestrated by intestinal
stem cells, are poorly understood. We discovered that, in mice with Citrobacter rodentium (CR)-induced
infectious colitis, treatment with Pectin and Tributyrin diets reduced the severity of colitis by restoring
Firmicutes and Bacteroidetes and by increasing mucus production. RNA-seq in young adult mouse
colon (YAMC) cells identified higher expression of Lgr4, Lgr6, DCLK1, Muc2, and SIGGIR after
Butyrate treatment. Lineage tracing in CR-infected Lgr5-EGFP-IRES-CreERT2/ROSA26-LacZ (Lgr5-R)
mice also revealed an expansion of LacZ-labeled Lgr5(+) stem cells in the colons of both Pectin and
Tributyrin-treated mice compared to control. Interestingly, gut microbiota was required for Pectin
but not Tributyrin-induced Lgr5(+) stem cell expansion. YAMC cells treated with sodium butyrate
exhibited increased Lgr5 promoter reporter activity due to direct Butyrate binding with Lgr5 at
−4.0 Kcal/mol, leading to thermal stabilization. Upon ChIP-seq, H3K4me3 increased near Lgr5
transcription start site that contained the consensus binding motif for a transcriptional activator of
Lgr5 (SPIB). Thus, a multitude of effects on gut microbiome, differential gene expression, and/or
expansion of Lgr5(+) stem cells seem to underlie amelioration of colitis following dietary intervention.
Keywords: intestinal stem cells; lgr5; gut microbiome; Citrobacter rodentium; colitis; Pectin; Tributyrin;
short-chain-fatty-acids (SCFAs); bacterial infection; dietary intervention
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1. Introduction

iations.

The gastrointestinal tract is home to trillions of microbes called microbiota [1] that
protect against enteropathogens, contribute to normal immune function, and maintain
homeostasis in the gut [1]. Maintaining this functional balance is crucial for sustaining normal intestinal mucosa physiology, as disruptions have been linked to the pathophysiology
of various gastrointestinal complications, including inflammatory bowel disease (IBD) [2].
The gut microbiota is known to secrete small molecules and metabolites such as shortchain-fatty-acids (SCFAs), which play an essential role in maintaining intestinal functions
and homeostasis [3–5]. SCFAs, including acetate, Butyrate, and propionate, are produced
by the fermentation of fiber diet, e.g., Pectin, in the colon [3–5]. Indigestible carbohydrates
in the diet serve as fermentation substrates for anaerobic gut bacteria, which produce
SCFAs and other gases as end products [3]. It is known that IBD patients have lower fecal
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concentrations of SCFAs compared with healthy control subjects and are often linked to
higher disease severity [6]. Diet and ingested microbes can potentially change the gut
environment by creating competition amongst gut microbiota for resources, leading to
the alteration of the microbial community. Many health conditions, including IBD, have
been associated with specific alterations in gut microbiota composition, which affects host
energy, metabolism, and immunity [1,7–12].
The gut’s protective effects against external insults depend on the activity of a functional intestinal epithelium which is constantly maintained by the continuous and rapid
proliferation of undifferentiated cells located within the crypts [13]. The intestinal epithelium is renewed every 3 to 5 days, facilitated by tissue-specific stem cell markers located
at the base of the crypts [14]. Leucine-rich repeat-containing G protein-coupled receptor 5 (LGR5) is a protein that has been discovered as a marker of crypt basal columnar
stem cells in the intestine [14]. Studies have also highlighted that LGR5 is closely related
to two additional receptors, leucine-rich repeat-containing G protein-coupled receptor 4
(LGR4) and leucine-rich repeat-containing G protein-coupled receptor 6 (LGR6), which
share around a 50% identity and represent a structurally distinct category of transmembrane receptors [15,16] with specific functions in embryonic development and adult tissue
homeostasis [15,16].
In many adult tissues such as the intestinal epithelium with rapid proliferation, renewal, and regeneration rates, Wnt signaling is well documented as a master of epithelial
renewal, as seen by the rapid fall in epithelial regeneration following reduced Wnt activity [17]. Studies have also shown that Wnt signaling is the main driver of cell proliferation in
the gut [18–20]. Likewise, a study revealed that LGR4 and LGR5 potentiate Wnt/β-Catenin
signaling in response to R-Spondin proteins [15].
Citrobacter rodentium (CR) is a Gram-negative enteric bacterium that causes Transmissible Murine Colonic Hyperplasia (TMCH) in mice characterized by colon hyperplasia, a loss
of goblet cells, and increased inflammation depending upon the genetic background [21,22].
CR is a member of attaching and effacing (A/E) family of bacterial pathogens and models human enteropathogenic Escherichia coli (EPEC), and enterohaemorrhagic Escherichia coli
(EHEC) and can regulate the composition of commensal microbiota, the integrity of epithelial barrier, mucosal healing, and inflammation, making it a robust model to study the
pathogenesis of human intestinal disorders including Crohn’s disease, ulcerative colitis
(UC), and dysbiosis [23–25].
Previous findings have revealed the role of dietary fibers such as Pectin in maintaining
gastrointestinal homeostasis [26] by releasing metabolites such as Butyrate and SCFAs [3,26].
However, there is little understanding of the role of dietary fibers in regulating the expression of stem cell markers in mitigating colitis. Thus, this study aimed to determine
the effect of Pectin and Tributyrin diets on alleviating the effects of CR-induced colitis by
regulating crypt stem cell markers Lgr4/5/6 to regenerate epithelial crypts, modifying the
microbiome to restore homeostasis alongside augmenting tissue repair in infected mice.
2. Results
2.1. Pectin and Tributyrin Diets Ameliorate Symptoms of Colitis
Mice infected with CR developed colitis characterized by colon shortening, weight loss,
and general inflammation of the colonic tissue (Figure 1Ai,Aii). To characterize the integrity
of the colonic epithelial layer, we quantified the permeability of orally administered FITCdextran in serum. We found increased levels of serum FITC-dextran in CR-infected mice
(Figure 1Aiii). Pectin (CR+Pec) and Tributyrin (CR+Tbt) diets (diets hereafter), however,
showed a significant decrease in serum FITC-dextran (Figure 1Aiii). To further characterize
the protective effect of diets, we performed electron microscopy of mucosal epithelium.
We observed loss of microvilli and increased intercellular distance in CR compared with
N. Contrarily, in diet samples, microvilli were restored to some extent and intercellular
distances were minimized (Figure 1Bi,Bii). H&E staining revealed longer crypts and
immune cell infiltration in CR-infected mice compared to healthy control (N). However,
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the mice infected with CR and fed with diets showed a decreased infiltration of immune
cells (Figure 1Ci,Cii). We next analyzed the effect of diets on cell proliferation during CR
infection by staining colonic sections for the proliferation marker Ki67. Our results showed
an increased proliferation of crypt cells in CR-infected mice compared to the N. Diets
maintained the proliferation state of colon crypts (Figure 1Di,Dii). These results indicate
that CR infection-mediated infectious colitis is characterized by colon inflammation and
shortening, weight loss in the animals, increased FITC, increased crypt proliferation, and
immune cell infiltration. The Pectin and Tributyrin diet, on the other hand, reduced disease
Int. J. Mol. Sci. 2022, 22, x FOR PEER
REVIEW
4 of 28
severity
by restoring colon characteristics, maintaining mucosal epithelium, and preserving
crypt proliferation.

Figure 1. Pectin and Tributyrin diets ameliorate infectious colitis: (Ai). Representative images of

Figure 1. Pectin and Tributyrin diets ameliorate infectious colitis: (Ai). Representative images of
colons from uninfected normal mice (N), C. rodentium-infected (CR) and CR-infected, and Tributyrin
colons
from uninfected
normal
mice represent
(N), C. rodentium-infected
(CR) and CR-infected,
and
Tributyrin
diet-treated
mice (CR+Tbt)
(results
3 independent experiments).
(Aii). Average
weight
measurement of mice in various treatment groups from D0 to D12 post-infection (n = 5 per group).
(Aiii). Normal, CR, CR, and Pectin-treated (CR+Pec), and CR and Tributyrin-treated (CR+Tbt) mice
were subjected to gavage with FITC-D, and their serum concentrations were measured after four
hours (results represent 3 independent experiments; p < 0.05 compared to CR; Mean+SD) (Bi,Bii).
Electron microscopy (EM) of the mice is described in Panel A. Arrows represent tight junctions (Pec,
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diet-treated mice (CR+Tbt) (results represent 3 independent experiments). (Aii). Average weight
measurement of mice in various treatment groups from D0 to D12 post-infection (n = 5 per group).
(Aiii). Normal, CR, CR, and Pectin-treated (CR+Pec), and CR and Tributyrin-treated (CR+Tbt) mice
were subjected to gavage with FITC-D, and their serum concentrations were measured after four
hours (results represent 3 independent experiments; p < 0.05 compared to CR; Mean+SD) (Bi,Bii).
Electron microscopy (EM) of the mice is described in Panel A. Arrows represent tight junctions (Pec,
Pectin; Cell, Cellulose; Tbt, Tributyrin). (Ci,Cii). H&E staining in the colon sections prepared from
the indicated groups in C3H mice. Arrows indicate immune cell infiltration in the CR group. Bar
graphs represent average crypt length (* p < 0.05; ** p < 0.01 compared to N; Mean+SD; two-tailed
Student’s t-test). (Di,Dii). Representative staining for Ki-67 in the colon sections prepared from the
indicated groups in C3H mice. Scale bar = 100 µm; Bar graphs represent percent of Ki-67 positive
cells; (* p < 0.05; ** p ≤ 0.01); two-tailed Student’s t-test; results represent 3 independent experiments.

2.2. Pectin and Tributyrin Diets Enhanced MUC2 Secretion in CR-Infected Groups
Goblet cells are abundant in the colon than in other areas of the gastrointestinal tract
and are important for protecting the integrity of the intestinal mucosal barrier against
pathogens. Likewise, goblet cells are also responsible for secreting intestinal antimicrobial
peptides and mucins. We performed PAS/Alcian blue staining on the Carnoy’s fixed
colonic sections to identify all intracellular mucin glycoproteins [27,28]. As expected, there
was a loss of goblet cells and the inner mucus layer thickness in CR-infected mice compared
with N, while CR-infected mice put on diets were able to restore them (Figure 2A,B).
Figure S1A,B represents the average number of goblet cells/crypt.
Mucin-2 (Muc-2) is a major colonic mucin secreted by goblet cells and is protective
against CR infection [29]. We utilized the immunofluorescence of colon sections using the
anti-Muc2 antibody to ascertain the expression of Muc-2. We observed a significant loss of
Muc-2 secretion in CR-infected mice compared with controls (Figure 2C,D). Diets, however,
enhanced the secretion of Muc2 significantly (Figure 2C,D). Figure S1C,D represents average
number of Muc2+ cells/crypt. Muc-2 depletion during infection is also correlated with
an impaired intestinal mucus layer [30]. To investigate whether the impaired mucus
layer caused by the infection increased bacterial access to epithelium and subsequently
contributed to colitis, we performed staining to detect luminal bacteria via fluorescence-insitu-hybridization (FISH) with the universal bacterial probe EUB338. Staining of Carnoy–
fixed colon sections indicated that the bacteria in the CR-infected samples resided on the
epithelial surface, which was in contrast with N, where the mucus layer separated bacteria
from the epithelial layer. The addition of the diet, however, increased the distance between
the bacteria and epithelial barrier due to mucus production and hence disallowing bacteria
to bind with the epithelial surface (Figure 2E,F). Together, these results suggest that Pectin
and Tributyrin diets alleviate colitis-associated goblet cell depletion by increased secretion
of Muc2.
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Scale
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Please note how both Pectin and Tributyrin diets restrict bacterial movement near the mucosa, marked
by dashed lines. N= normal mice/control; C. rodentium-infected (CR); mice infected with CR and fed
a cellulose diet (CR+Cell); mice infected with CR and fed a Pectin diet (CR+Pectin); mice infected
with CR and fed with Tributyrin diet (CR+Tributyrin).
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2.3. Microbial Diversity and Composition Changes Following Pectin Diet
CR infection has been associated with dysbiosis of colonic microbiota [31]; likewise,
fiber diets have been shown to release SCFAs through bacterial fermentation, which promotes the growth of beneficial bacteria in the gut [32]. To investigate the impact of diets on
gut microbiota composition and whether they can reverse the CR-induced dysbiosis, we
analyzed colon microbiota dynamics of mice fed with Pectin compared with the control diet
using bacteria16S rRNA gene sequencing. We observed a significant expansion of bacteria in
the phylum Proteobacteria coupled with a concomitant decrease in the phylum Bacteroidetes
and Firmicutes in the CR-infected mice (Figure 3A). CR+Pec mice were highly responsive to
diet change and decreased the growth of Proteobacteria while increasing the abundance of
Bacteroidetes and Firmicutes in a pattern similar to the control groups (Figure 3A). To better
understand the impact of Pectin on the microbial community of CR-infected mice, we studied the correlation between Pectin diet and the taxonomic composition at the family and
operational taxonomic unit (OTU) level. We observed an overgrowth of Enterobacteriaceae
and Bacteroidaceae alongside a decrease in the S24-7 family of bacteria in CR-infected mice
compared with control (Figure 3B). In contrast, CR+Pec mice showed a significant diminution of Enterobacteriaceae, an increase in S24-7 bacteria, as well as a corresponding increase
in the abundance of Butyrate-producing bacteria such as Lachnospiraceae, Lactobacillaceae,
and Ruminococaceae (Figure 3B). Alpha-diversity, which describes diversity within a sample
and is measured by the PD Whole Tree (Figure 3C), observed OTUs (Figure 3D), and the
Chao1 index (Figure 3E), all decreased significantly with CR infection. However, the Pectin
diet increased these indices significantly (p < 0.05) (FDR ≤ 0.05) (Figure 3C–E). β-diversity
describes the microbiome diversity between samples and can be described using principal
component analysis (PCoA) based on the weighted and unweighted UniFrac distance
(Figure 3F), LEfSe or linear discriminant analysis (LDA) using a horizontal bar graph
(Figure 3G), or by using a LEfSe cladogram (Figure 3H). The distinct clustering of the N
group, visible through the β-diversity analysis, indicated abundant bacterial species in the
N group that significantly diminished with CR infection. Pectin-treated samples clustered
better than CR, indicating increasing bacterial abundance (Figure 3F–H). The PCoA showed
differences in the cluster of bacteria between the three different groups; moreover, in the
second plot (Figure 3F), which was from a different animal, there is a similarity in the cluster
observed in the control and Pectin-fed group suggesting that the Pectin diet may have
restored the bacteria groups to normal (Figure 3F). Taxonomic analysis also showed that
increased diversity of bacteria in the N group diminished with CR infection (Figure 3G–H).
These results suggest that the Pectin diet may have dual role in either preventing the loss
of key bacteria or restoring microbial diversity in the infected mice.
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Investigation with the Tributyrin diet produced almost similar results with a decrease
in relative abundance of Firmicutes but an increase in Proteobacteria in CR-infected mice
compared to control (Figure S1). In response to Tributyrin, while Bacteroidetes were not
affected, we did see a relative increase in Firmicutes with a concomitant reduction in
Proteobacteria (Figure S2). Lack of detailed alpha- and β-diversity measurements in the
Tributyrin-fed group remains a limitation of this study.
2.4. Pectin Fermentation Product Butyrate Induces Differential Expression of Genes Involved in
Epithelial Regeneration and Repair
In order to have a better understanding of how diet mitigates infectious colitis together
with delineating the effect of SCFAs such as Butyrate on epithelial wound healing and
repair, we decided to conduct an RNA-seq analysis on young adult mouse colon cells
(YAMCs) treated with sodium butyrate in vitro. We present volcano plots and heatmaps of
differentially expressed genes that were upregulated and statistically different in the three
groups (Table 1). We noticed that a larger pool of genes was differentially expressed in the
CR+Butyrate (CR+B) vs. control group and CR+B vs. CR group (Figure S3A–F). Thousands
of differentially expressed genes were identified but were streamlined to specific genes
involved in cytokine production, transcription regulation, protective effect, and epithelial
repair, with p-value (p ≤ 0.05), false discovery rate FDR ≤ 0.05, and a fold change greater
than 1.5. (Table S1). We found upregulation of anti-inflammatory genes IL18, IL4, and
IL33 after Butyrate treatment (Butyrate vs. CR). These genes had decreased expression
in the CR vs. control group (Figure 4). Likewise, we observed the downregulation of
the proinflammatory gene IL6 in the Butyrate vs. CR group, which, in contrast, was
upregulated in the CR vs. control (Figure 4). We also identified the upregulation of tissuespecific stem cell markers LGR4 and LGR6 in both the Butyrate vs. control group as well as
Butyrate vs. CR group (Figure 4, Figure S3D,E). Contrarily, the expression of these stem cell
markers declined in the CR-infected group (Figure 4). Wnt ligands WNT2B, WNT7A, and
receptor FZD9 also had increased expression after Butyrate treatment. In the same light,
Wnt pathway agonists RSPO1 and RSPO3 and co-receptors LRP5 and LRP6 had increased
expression in the Butyrate vs. CR group (Figure 4), suggesting a possible upregulation of
the Wnt pathway after Butyrate treatment.
Table 1. List of designated genes differentially regulated in response to either CR infection or CR
infection coupled with Butyrate treatment shown here as fold change (representative of 3 biological
replicates).
Genes

Fold Change CR Infection vs.
Control

Fold Change Butyrate
Treatment vs. Control

Fold Change Butyrate
Treatment vs. CR Infection

DCLK 1
DLL1
FZD9
HES 1
IL 18
IL 33
IL 4
IL 6
JAG 1
LEF 1
LGR 4
LGR 6
LRP 5
LRP 6
MUC 2
MYC
NOD 2
NOTCH 3

−2.5
−1.8
2.2
−1.2
−2.1
−1.7
1.1
3.2
−1.1
1.4
−1
1.6
−1
−1.1
−1
1.7
1.5
−1.2

−1.1
1.5
6.1
1.2
−1.3
1.8
2.3
2.1
4.6
10.4
2.2
9.1
1.5
1.5
8.7
2.3
12.2
10.6

2.3
2.7
2.8
1.4
1.6
3.1
2.1
−1.5
5.1
7.5
2.2
5.7
1.5
1.7
9.1
1.4
7.9
12.3
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Table 1. Cont.
Genes

Fold Change CR Infection vs.
Control

Fold Change Butyrate
Treatment vs. Control

Fold Change Butyrate
Treatment vs. CR Infection

NOTCH 4
RSP0 1
RSP0 3
SIGIRR
TGF-Alpha
TGF-Beta
VILL
WNT 2B
WNT 7A

−1.6
−3.4
−1.2
1.8
2.1
−1.7
−1.9
−3.1
1.4

4.5
−1.3
2.8
28.9
21.1
10
10.6
−1.3
52.6

7.4
2.6
3.4
16.3
10.2
17
20.5
2.3
36.3

Schematic of the proposed physiological changes with Butyrate treatment after CR infection, this model was used
11 of 28
to suggest a possible role of SCFAs such as Butyrate in mitigating CR-induced colitis. The image includes selected
cytokines, genes involved in stem cell maintenance, protective effects, cellular homeostasis, and wound healing.
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DCLK1, or doublecortin-like kinase 1, is a marker of intestinal tuft cells that has been
shown to improve epithelial repair responses, limiting bacterial invasion into the mucosa
[33]. We found upregulation of DCLK1 in the Butyrate vs. CR group and a decreased expression of DCLK1 after CR infection (Figure 4, Figure S3B). MUC-2, which has been primarily associated with epithelial repair and mucosal barrier sustenance [29,30], showed
increased expression after Butyrate treatment (Figures 4 and S3B). NOTCH3 and
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DCLK1, or doublecortin-like kinase 1, is a marker of intestinal tuft cells that has
been shown to improve epithelial repair responses, limiting bacterial invasion into the
mucosa [33]. We found upregulation of DCLK1 in the Butyrate vs. CR group and a
decreased expression of DCLK1 after CR infection (Figures 4 and S3B). MUC-2, which has
been primarily associated with epithelial repair and mucosal barrier sustenance [29,30],
showed increased expression after Butyrate treatment (Figures 4 and S3B). NOTCH3 and
NOTCH4 receptors alongside JAG1 ligand of the Notch pathway were upregulated in the
Butyrate vs. CR group (Figures 4 and S3D,E) and contrarily downregulated in the CR vs.
control group. Wnt and Notch signaling facilitate wound healing in the cutaneous layer
of the skin [34]; in lieu of this, we opine that upregulation of Wnt and Notch pathways,
increased expression of DCLK1, MUC-2, nucleotide-binding oligomerization domain 2
(NOD2), and anti-inflammatory markers all promote epithelial regeneration after CR
infection.
2.5. Pectin and Tributyrin Diets Regulate Lgr5 Expression
Our RNA-seq data revealed the upregulation of LGR4 and LGR6 but not LGR5 after
Butyrate treatment. However, previous studies have confirmed that LGR5 is highly related
to LGR4 and LGR6, with over 50% similarity in structure [14,15]; they are also grouped
together as type B receptor family of proteins or the G-protein-coupled, 7-transmembrane
(7TM) family of proteins [14–16]. In view of this, we decided to test whether the beneficial
effect of diets on colonic epithelium is related to the increased expression of Lgr5+ stem cells.
We examined the effects of diets on Lgr5+ colonic stem cells in Lgr5CreERT2/Rosa26LacZ
reporter (Lgr5-R) mice [14] during CR infection (Figure 5A). The administration of Pectin
and Tributyrin diets significantly enhanced LacZ staining in the colons of these mice when
compared with CR, indicating that Pectin and Tributyrin diets could induce the expression
of Lgr5 in the colonic crypts (Figure 5B). Figure S4A represents average number of LacZ+
cells/crypt. Additionally, quantitative PCR of Lgr5 in whole animal tissues revealed
a decline in Lgr5 expression after CR infection with a slight restoration following diet
intervention (data not shown). We next verified whether the induction of Lgr5 by diets
required the presence of microbes. To do so, we gave a cocktail of antibiotics to Lgr5-R
mice infected with CR and fed them with a 6% Pectin (CR+Pec) or Tributyrin (CR+Tb) diet,
respectively. The antibiotics treatment significantly reduced LacZ staining in the crypts
of CR+Pec but not in CR+Tb mice, indicating that Lgr5 induction was indeed driven by
microbiota (Figure 5C). Figure S4B represents the average number of LacZ+ cells/crypt.
To see whether antibiotic treatment was able to slow down the crypt proliferation, we
performed Ki-67 staining on the colon sections. As expected, CR-infected mice fed with a
Pectin diet and treated with antibiotics showed a decrease in Ki-67 staining compared with
control (Figure 5D), while antibiotics did not have a similar effect on the mice fed on the
Tributyrin diet (Figure 5D). Figure S4C represents the average number of Ki-67+ cells/crypt.
We acknowledge that the lack of 16S rRNA gene sequencing in antibiotics-treated samples
is a limitation of the study.
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models of molecular docking revealed that Butyrate binds within the protein cavity of Lgr5 (binding
energy = −4.0 Kcal/mol) and forms hydrogen bonds with Asp290 (2.3 Å) and Phe288 (2.0 and
2.6 Å). Green: Butyrate; Yellow: Interacting amino acids; Red–White–Blue: Lgr5 protein surface view.
(D). Western blot of HEK293 cells treated with different concentrations of sodium butyrate for two
hours and then subjected to thermal denaturation at different temperatures for 3 min. Cell lysates
were prepared and following SDS-PAGE membranes were probed with Lgr5 antibody. Please note
Lgr5 stabilization at higher temperatures when incubated with different concentrations of Butyrate
compared to control. (E). Results from the densitometric evaluation of CETSA assays. CETSA:
Cellular Thermal Shift Assay, Secreted Alkaline Phosphatase (SEAP); NaB: Sodium Butyrate; NaCl:
Sodium Chloride.

2.7. Butyrate Promotes Active Transcription of Lgr5 through SPIB
Histone modifications are well-recognized mechanisms that mediate the alteration
of gene expression [35]. We performed ChIP-sequencing using young adult mouse colon
cells (YAMCs) with antibodies specific to histone H3-lysine 27 acetylation (H3K27Ac),
histone H3-lysine 9 acetylation (H3K9Ac), and histone H3-lysine 4 methylation (H3K4me3)
modification. The number of significantly enriched regions detected for each histone
modification marker is described in Figure 7E. The distribution of differential binding
events of the H3K27ac marker compared across N, CR, and CR-B is given in Figure S3.
CR constituted the highest number of unique H3K27ac sites (50.87%), followed by CR-B
(37.12%) and N (6.4%) (Figure S5). There were several sites enriched for the H3K27Ac
marker around a 100 kb region from the transcription start site (TSS) of the Lgr5 gene in both
CR (10 sites) and CR-B (8 sites) but not in N (2 sites) (Figure 7A). Two of these sites upstream
(12,697 bp and 79,049 bp from the TSS) in CR group and one site overlapping (5972 bp
from the TSS) in the CR-B group contained consensus binding motif for Neurogenin 1
(NEUROG1), which is known to regulate Lgr5 [36]. We also found that histone H3 trimethylation at lysine 4, a mark of active transcription [35], was increased near Lgr5 TSS
in CR+B-treated cells (Figure 7B). Several sites were enriched for the H3K4me3 marker
around a 100 kb region from the TSS of the Lgr5 gene in all three conditions (N: 7, CR: 8,
CR-B: 9) (Figure 7B). Two of these sites were upstream (8357 bp and 46713 bp from the TSS)
of Lgr5 in N and four sites (one 25831 bp upstream and three downstream overlapping
the gene at 26813 bp, 38716 bp, 69891 bp from the TSS) in CR+B contained the consensus
binding motif for the Spi-B transcription factor (SPIB), a transcriptional activator which is
known to induce Lgr5 expression [37,38]. The differential expression of SPIB was also seen
in the RNA-seq data, wherein decreased expression was observed in CR vs. control group,
which was upregulated after Butyrate treatment (Table S1). This suggests that Butyrate
may promote active transcription of Lgr5 by inducing the expression of SPIB.
The distribution of differential binding events for H3K9Ac, a marker of active transcription [35], was also compared across N, CR, and CR-B and is given in Figure S5. CR
contained the highest number of unique H3K9ac sites (92.2%), followed by CR-B (3.9%) and
N (3.0%) (Figure 7C). The Lgr5 gene had two sites upstream (8413 bp and 88142 bp) of its
TSS enriched for H3K9ac in CR and contained conserved binding motifs for 14 known TFs
(Figure 7D). The site, 88,142 bp upstream from its TSS, contained conserved binding sites
for eight TFs, including Neurogenin1 (NEUROG1), a transcriptional regulator of Lgr5 [36].
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3. Discussion
In this study, we demonstrate that Pectin and Tributyrin diets mitigate infectious
colitis through a multitude of events, including recruitment of the stem cell markers
Lgr4, Lgr5, and Lgr6 to promote crypt regeneration, partial reversal of bacterial dysbiosis,
increased expression of MUC2, DCLK1, NOD2, SIGIRR (single immunoglobulin IL-1Rrelated molecule), and several other anti-inflammatory genes.
Ulcerative colitis and other intestinal degenerative diseases are common human disorders, as new UC cases seem to be increasing globally [39]; yet, the clinical interventions
are limited, as the pathological mechanisms are not very clear. Citrobacter rodentium (CR)
infection is a robust model to study the pathogenesis of human intestinal disorders including colitis; CR infection leads to weight loss, shortening of the colon, loss of epithelial
barrier integrity, bacterial translocation into lamina propria, crypt hyperplasia, goblet cell
depletion, loss of inner mucus layer, alteration in microbiota composition and colon inflammation [22,23,26,40–42]. Studies have also shown that mice lacking the inflammasome
components Nlrp3, Nlrc4, and caspase-1 are hypersusceptible to Citrobacter rodentiuminduced gastrointestinal inflammation [43].
Diet is the main contributor to the gut microbial composition, diversity, and richness [44–48], and changes in the diet can account for 57% of the variations in microbiota,
while genetic variations in the host can account for only 12% [49]. Several studies have
shown a strong connection between diet and microbiota, signifying how the composition
of different diets directly impacts gut microbiota [45,47,48,50]. In the current study, we observed the predominance of Enterobacteriaceae during CR infection. However, the Pectin diet
inhibited the growth of Enterobacteriaceae and enhanced the growth of Butyrate-producing
bacteria such as Lachnospiraceae, Lactobacillaceae, and Ruminococaceae. This data suggests
that the Pectin diet modulates the gut microbiota to resist CR colonization and CR-induced
dysbiosis. At the same time, the Pectin diet seems to have either boosted the growth and/or
retention of healthy bacteria, particularly those involved in Butyrate production. This
phenomenon seems to be duplicated by the Tributyrin diet, although the mechanisms
detailing whether Tributyrin’s effect is mediated by Butyrate remain a limitation of this
study. We also observed that all diets were able to produce a protective mucus layer on top
of the epithelial cells to act as a barrier to pathogens [23]. Increased pathogen susceptibility
to CR due to the loss of mucus production in our study parallels previous studies [29],
while IBD patients tend to harbor higher levels of mucolytic bacteria that can degrade
mucin [51]. This could be attributed to the low intake of dietary fibers with associated
decreases in Firmicutes and/or Bacteroidetes and an overabundance of Proteobacteria, all of
which are critical in the pathogenesis of IBD [52].
Employing RNA-seq, we present a model of differentially expressed genes after
Butyrate treatment to propose a possible mechanism of Butyrate action on mitigating
colitis (Figure 4). With the increased expression of MUC-2 after diet (Figures 2 and 4),
Butyrate seems to have stimulated MUC-2 secretion to restore the barrier function against
bacterial infection in the gut. This is supported by a previous investigation that revealed
that MUC-2-deficient mice are vulnerable to colitis and death caused by CR infection [29].
Interestingly, RNA-seq analysis also revealed that genes that exert protective effects in
the intestinal epithelium, such as DCLK1 and NOD2, were all upregulated (Figure 4) after
Butyrate treatment. DCLK1 is a microtubule-associated protein that marks long-lived,
quiescent epithelial tuft cells in the intestine [53], and recent studies have revealed that
deletion of DCLK1 led to worsened colitis [33,53]. Likewise, NOD2 modulates innate
responses to intestinal microflora by downregulating numerous TLR responses, and the
lack of this regulation increases susceptibility to colitis [54].
Cytokines, which are essential mediators of both proinflammatory and anti-inflammatory
processes, are crucial in progressing immunological alterations and chronic inflammation
in IBD [55]. This study discovered the upregulation of anti-inflammatory cytokines IL33,
IL18, and IL4 and the downregulation of proinflammatory cytokine IL6 (Figure 4). IL33
has been described as a dual function protein, however a recent study indicated that IL-
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33 attenuates chronic intestinal inflammation by promoting epithelial regeneration and
weight recovery in infected mice [56]. In the same light, IL18 has been implicated as a
dual role cytokine in colitis, and it was proposed that the anti-inflammatory effects of
IL-18 may be observed in the early stages of colon inflammation [57]. A study on human
IL4-treated regulatory macrophages also revealed that IL4 treatment promoted epithelial
wound healing and reduced the severity of colitis in mouse models [58]. Contrarily,
IL6 is a proinflammatory cytokine with higher severity of colitis being associated with
increased IL6 expression [59–61]. A reduction in IL6 expression was observed in the
Butyrate vs. control and Butyrate vs. CR-infected group after RNA seq analysis (Figure 4).
We speculate that Butyrate treatment promotes epithelial repair through the upregulation
of anti-inflammatory genes and the downregulation of proinflammatory markers during
CR infection.
Another possible mechanism of Pectin and Tributyrin diets ameliorating colitis may be
through the activation of the Wnt pathway. Wnt/β-catenin signaling has been described as
the fundamental organizer of epithelial stem cell identity and maintenance [18,62]. Active
Wnt signaling is required for epithelial homeostasis in the intestine, and pathway blockage
has been associated with crypt loss and tissue degeneration [63]. R-Spondins (RSPO1-4)
are Wnt agonists and have been described as the endogenous ligands of the Lgr-expressing
(Lgr4/Lgr5/Lgr6) stem cells, with studies demonstrating the critical involvement of Lgr
proteins in stem cell homeostasis in the gastrointestinal tract [13–15,63]. Our study revealed
an increased expression of Wnt receptor and ligands, as well as R-Spondins and Lgrproteins Lgr4/Lgr5/Lgr6 (Figures 4 and 5), suggesting the upregulation of the Wnt pathway
in a bid to repair the damaged epithelium. Furthermore, Lgr5+ stem cells play a significant
role in the homeostasis and regeneration of the gut epithelium [13,64,65]. Similarly, lactate
plays a vital role in maintaining the stemness of Lgr5+ ISCs by activating the Wnt-β-catenin
pathway [66]. Indeed, we found a significant increase in the Lgr5+ stem cell population
in the colons of mice fed with Pectin and Tributyrin diets compared to controls. We also
found an increase in the active transcription of Lgr5 via SPiB from our ChIP seq analysis
that correlates with the previous finding that RankL-induced expression of SpiB is essential
for Lgr5 stem cell-derived epithelial precursors to develop into M cells [37]. The increased
Lgr5-expressing cells likely contribute to the proliferation and restitution of the inflamed
colon. Remarkably, a recent study also revealed that NOD2 mediates LGR5+ intestinal
stem cell protection against ROS cytotoxicity [67], suggesting that an increased expression
of NOD2, as observed in our study, may also potentiate the activity of Lgr5+ stem cells.
Since SCFAs, including Butyrate, are produced from Pectin through the actions of
gut microbiota, and because Butyrate release from Tributyrin requires host lipases [68],
we explored the question of whether microbiota regulated stem cells through Butyrate.
Our findings indicate that, while both Pectin and Tributyrin diets increased Lgr5+ stem
cells, treatment of Pectin-fed mice with antibiotics severely impacted Lgr5 expression, and
there was no significant difference in mice fed with the Tributyrin diet and treated with
antibiotics. Pectin-fed mice receiving antibiotics also showed significantly less proliferating
crypts, and this was not evident in the Tributyrin+Abx group. These results infer that Pectin
and Tributyrin diets increased Lgr5 expression in the colonic tissue, leading to the increased
proliferation of colonic crypts. We acknowledge that Kaiko et al.’s elegant study recently
revealed that the differentiated colonocytes that consumed Butyrate may have prevented it
from reaching the proliferating epithelial stem/progenitor cells within the crypt during
normal homeostasis [69]. However, we and others have shown that CR infection leads
to the remodeling of the mucosa, wherein mitotically active colonocytes could be seen
even at the crypt surface [41,70,71]. These cells may continuously be exposed to Butyrate
levels that may be sufficient to sustain crypt proliferation through stem cell expansion.
This study proposes that a Pectin diet, probably through the generation of SCFAs, protects
the colonic epithelium in colitis-infected mice by reducing hyperplasia and restoring gut
homeostasis via lgr5+ stem cell expansion. We propose that the crypt is damaged during
colon inflammation, resulting in the loss of differentiated cells. In this scenario, we believe
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that crypt base columnar (CBC) cells use Butyrate to gradually restore homeostasis, as seen
in the restoration of Wnt/Notch pathways, which eventually expands Lgr5+ stem cells to
promote the renewal of the damaged Crypt.
The signals received from the mesenchymal cells are critical for the maintenance of the
stem cell niche. Epithelial response to the disruption of these signals is a critical feature of
the intestine’s ability to respond to injury by regulating barrier function, the composition of
the microbiota, and mucosal immune homeostasis. We provide evidence that a Pectin diet
restores barrier function and mitigates colitis by retaining/restoring healthy bacteria and
expanding the stem cell population in the crypt. We also demonstrate for the first time the
effect of Butyrate on Lgr5 binding and stabilization via the transcription factor SPIB. With
this new discovery, we hypothesize that the supplementation of Butyrate and probably
other SCFAs in diets will be highly beneficial in reducing intestinal injury in response to
enteric pathogens.
4. Methods
4.1. Animals
C57Bl/6 and C3H/HeNHsd (C3H) inbred mice were procured from Harlan Laboratories Inc., Indianapolis, IN, USA. C3H mice respond very aggressively to CR infection
and are used as an excellent model of infectious colitis [70]. Lgr5-EGFP-IRES-CreERT2 and
Rosa26LacZ mice were purchased from Jackson Laboratories. All the mice were maintained
in a specific pathogen-free (including Helicobacter and parvovirus) environment and are
generally used between 5 and 6 weeks of age. For control groups, either littermates or
WT mice of identical backgrounds were used. Animals were placed on diets on the third
day after CR infection. Mice were placed into control group (N), CR-infected group (CR),
CR-infected and cellulose-fed group (Cell), group fed with Pectin (CR+Pec), and the group
fed with the Tributyrin diet (CR+Tbt). A minimum of five animals were used in each group.
This study was carried out in strict accordance with the recommendations in the Guide for
the Care and Use of Laboratory Animals of the National Institutes of Health. All protocols
were approved on 10/20/2017 by the University of Kansas Medical Center Animal Care
and Use Committee (IACUC) under the protocol #2017-2425. All mice were maintained in
a pathogen-free environment and housed in cages in groups of five animals per cage with
constant temperature and humidity and a 12hr/12hr light/dark cycle. All animals always
had access to diet and water.
4.2. Lineage Tracing
Lgr5-EGFP-IRES-CreERT2 and Rosa26LacZ mice were purchased from Jackson laboratories and cross bred to generate Lgr5-EGFP-IRES-CreERT2/Rosa26LacZ (Lgr5.R) mice.
Six-to-ten-week-old male and female mice were used for all studies. Cre recombinase was
activated in Lgr5.R mice by intraperitoneal injections of tamoxifen (100 µL of 10 mg/mL
tamoxifen dissolved in sunflower oil) given on days 6, 7, and 8 post-infection. Dissected
colons were fixed with paraformaldehyde, and the LacZ+ve progeny of the Lgr5+ve stem
cells were visualized in the colon by β-galactosidase staining [15].
4.3. Treatments and Humane Endpoints
Transmissible Murine Colonic Hyperplasia was induced in the mice by oral inoculation
with a 16-h culture of C. rodentium strain DBS100 (108 CFUs) identified as pink colonies
on MacConkey agar, as previously described [23,70,72]. Age and sex-matched control
mice received sterile culture medium only. We employed the standard AIN-93 diets from
Envigo (TD.94045) containing, in g/kg: casein 200, DL-methionine 3.0, corn starch 347.311,
maltodextrin 130, sucrose 160, soybean oil 70, vitamin mix AIN-93 10, choline bitartrate
2.5, antioxidant TBHQ 0.014, cellulose 50, calcium 12. For the Pectin diet, AIN-93 diet
was modified to contain: 335.686 g corn starch, 60 g Pectin (6% Pectin; TD.97202), and no
cellulose. Tributyrin diet was procured from TestDiet (6%; Cat#1814961). Mice in the Pectin
and Tributyrin group were put on the diet on the third day after CR infection. Mice were
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then euthanized after 12 days post-infection. For microbiota depletion experiments, mice
were given a cocktail of vancomycin (500 mg/L), metronidazole (1 g/L), and ciprofloxacin
(0.2 g/L) for 10 days, starting 3 days post-CR infection. Mice were monitored daily by our
trained laboratory and veterinary staff to minimize stress and suffering. Animals were
immediately euthanized when they showed signs of severe distress, discomfort, loss of
weight, and poor prognosis, following consultation with the veterinarians.
4.4. Histology and Electron Microscopy
Colon tissues were freshly harvested from mice and fixed with 10% neutral buffered
formalin or in Carnoy’s fixative (60% methanol, 30% chloroform, and 10% acetic acid) prior
to paraffin embedding. Paraffin-embedded sections (5 µm) were stained with Hematoxylin
and Eosin for morphology using standard techniques. Goblet cells were stained with PAS
(Richard-Allan Scientific) or Alcian blue (Thermo Fisher Scientific, Waltham, MA, USA)
and counterstained with Nuclear Fast Red (Sigma-Aldrich, St. Louis, MO, USA). The
pictures were obtained with a Nikon i80 microscope. For electron microscopy, mouse distal
colons from uninfected normal mice or C. rodentium-infected or C. rodentium-infected and
diet-treated mice were minced into small cubes, fixed in 4% paraformaldehyde and 2%
glutaraldehyde in cacodylate buffer (0.1 M sodium cacodylate, pH 7.6) overnight at room
temperature, and postfixed in 1% osmium tetroxide for 90 min. The fixed tissues were
dehydrated through a graded series of Ethanols, embedded in Epon-araldite resin, and
maintained for 48 h at 60 ◦ C for polymerization. Ultrathin (100 nm) sections cut on a Leica
UC-6 ultramicrotome were placed on glow-discharged 300-mesh copper grids and stained
with uranyl acetate and Sato’s lead to enhance contrast. Ultrathin sections were examined
with a Hitachi H-7600 electron microscope.
4.5. Immunohistochemistry
Paraffin-embedded sections were dewaxed with xylene and rehydrated in graded
series of ethanol. Tissue sections were then washed with PBS before starting the staining
procedure. Immunohistochemistry was done using Histostain-SP kit (Invitrogen, Waltham,
MA, USA) following their instructions. Briefly, deparaffinized sections were boiled for
20 min in a 0.01 M citrate buffer at pH 6.0 for epitope retrieval. The sections were then
blocked for 10 min using a serum blocking solution. Sections were incubated for 1 h at 4 ◦ C
with primary antibodies. After three washings for five minutes each in PBS, sections were
subsequently incubated with biotinylated secondary antibodies for 10 min, followed by
10 min incubation with enzyme streptavidin–peroxidase conjugate. A 3–5 min incubation
followed this with DAB solution containing diaminobenzidine (DAB) chromagen for
development and 0.6% H2 O2 to inhibit endogenous peroxidase activity. The sections were
finally counterstained with hematoxylin, dehydrated with a graded series of ethanol, and
cleared in xylene. After staining, the sections were mounted with mounting medium, and
images were obtained and analyzed with a Nikon 80 microscope.
4.6. Immunofluorescence
After dewaxing and rehydration, tissue sections were incubated with relevant primary
antibodies overnight at 4 ◦ C. After incubation, the slides were washed three times in PBS
for five min each. The secondary antibody staining was performed by covering the tissue
sections with a 1:1000 dilution of Alexa Fluor 488/594 conjugated goat anti-rabbit/antimouse IgG antibody (original concentration: 2 mg/mL; Thermo Fisher Scientific, USA) in
blocking buffer, and the sections were incubated for 1 h at room temperature in the dark.
The excess liquid was blotted away, and the sections were rinsed twice for 5 min each using
PBS. Next, the sections were stained for 5 min at room temperature in the dark using a
10 mg/mL of DAPI solution diluted in 1× PBS (Sigma-Aldrich, MO, USA). The sections
were then rinsed with Milli-Q water and blotted dry. Finally, the sections were covered
with ProLong Gold Antifade Mounting media (Invitrogen, Waltham, MA, USA), covered
with coverslips, and the edges of the coverslips were sealed with nail polish. The slides
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were kept at room temperature in the dark for at least 24 h and then visualized by Nikon
i80 upright fluorescence microscope.
4.7. Fluorescence In Situ Hybridization (FISH)
FISH was performed according to the method described previously with some modification [73]. Paraffin sections were dewaxed and rehydrated in an ethanol gradient to
water. The tissue sections were incubated with 5 µg/mL TexasRed-conjugated EUB338
(50 - GCTGCCTCCCGTAGGAGT-30 , Invitrogen) in hybridization buffer (0.1M Tris-HCl,
0.9 M NaCl, 0.1% SDS and 10% formamide, pH 7.2) at 40 ◦ C overnight. The sections were
rinsed in washing buffer (20 mM Tris-HCl, 0.9 M NaCl, pH 7.4) at 40 ◦ C for 15 min and
stained with 1 µg/mL DAPI. After staining, the sections were mounted with ProLong Gold
mounting medium (Invitrogen). All images were obtained and analyzed with a Nikon i80
microscope.
4.8. Bacterial DNA Extraction
Fresh feces from mice were used to extract microbial DNA using the QIAmp DNA stool
kit (Qiagen, Valencia, CA, USA), following their instructions. The integrity, concentration,
and quality of the total DNA were assessed by agarose gel electrophoresis and determined
by absorption at A260 and the A260 to A280 ratio, respectively, using a Nanodrop-2000
spectrophotometer (Thermo Fisher Scientific Inc., USA). DNA solutions were stored at
−20 ◦ C until further analysis.
4.9. Microbial Analysis Using 16S Ribosomal DNA Library Preparation and Sequencing
Using fecal DNA, the hypervariable V3–V4 region of the 16S ribosomal RNA (rRNA)
gene was amplified from each sample using barcoded universal bacterial primers and, subsequently, sequencing was done on the Illumina MiSeq platform using custom primers [73].
The resulting sequences were analyzed using the QIIME2 (Quantitative Insights Into Microbial Ecology; http://www.qiime2.org, accessed on 9 November 2021) analysis pipeline [74].
FASTA-quality files and a mapping file indicating that the 8-nucleotide barcode sequence
corresponding to each sample was used as inputs. Reads were trimmed and demultiplexed
using exact matches to the supplied DNA barcodes. Any reads with homopolymer runs,
more than 6 ambiguous bases, nonmatching barcodes, barcode errors, or quality scores less
than 25 were removed. Samples with less than 3500 sequences were also removed. The
resulting sequences defined at 97% similarity threshold were assigned to operational taxonomic units (OTUs), and taxonomical classification was performed using the greengenes
13_8 database. Core diversity, including alpha and beta diversity analysis, was performed
on OTU tables using QIIME software. The resulting raw sequence files (.fastq.gz) were
submitted to the NCBI Sequence Read Archive (SRA) database.
4.10. Functional Profiling of the Microbial Community
Prediction of functional profiling of microbial communities based on 16S rDNA sequences was performed using Phylogenetic Investigation of Communities by Reconstruction of Unobserved States (PICRUSt) (release 1.0.0) [75]. The OTU tables were normalized
by dividing each OTU by the known/predicted 16S rRNA gene copy number abundance.
The metagenome functional content was predicted using the Kyoto Encyclopedia of Genes
and Genomes (KEGG) Orthology (KO) classification scheme. The predicted metagenome
BIOM table was analyzed and visualized using the Statistical Analysis of Taxonomic and
Functional Profiles (STAMP) software package v. 2.0.9. The linear discriminant analysis
effect size (LEfSe), an algorithm for biomarker discovery that identifies enrichment of
abundant taxa or function between two or more groups, was used to compare all taxa at
different taxonomic levels simultaneously (i.e., phylum, class, order, family, and genus)
between treatment groups.
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4.11. Fluorescein Isothiocyanate-Dextran (FITC-D) Assay
In vivo permeability assay to assess epithelial barrier function was performed using
FITC-D as described [76]. Briefly, food was withdrawn for 4 h from 5-to-6-weeks-old
C3H/HeN mice in various groups and gavaged with an 80 mg/100 g body weight of FITCD, (molecular weight 4000; Sigma–Aldrich). Serum was collected at the time of euthanasia,
blood cells were removed by centrifugation, and the fluorescence intensity of each sample
was measured with a fluorimeter (excitation, 492 nm; emission, 525 nm; FLUOstar Galaxy
2300; BMG Labtech, Durham, NC, USA). FITC-D concentrations were determined from
standard curves generated by the serial dilution of FITC-D, and permeability was calculated
by linear regression of sample fluorescence (Excel 5.0; Microsoft).
4.12. ChIP-Sequencing and Data Analysis
Young adult mouse colon cells (YAMCs) were cultured and infected as described
previously [77]. Cells were infected with CR for 3 h and treated with 5 mM sodium
butyrate (Sigma) for 24 h. YAMC with or without CR infection alone were used as a
control. The cells were then harvested and subjected to DNA immunoprecipitation using a
Magna ChIP A/G kit (Millipore) following the manufacturer’s instructions. Briefly, fresh
formaldehyde was added to the media for a final concentration of 1% for 10 min at room
temperature to cross-link proteins to DNA. Cross-linking was stopped by the addition of
0.125 mmol/L glycines for five minutes at room temperature. Cells were then lysed in
Cell Lysis Buffer containing 1X Protease Inhibitor Cocktail II. Lysates were sonicated on
a refrigerated water bath (Bioruptor Standard) for 12 cycles of 20 s on/20 s off at a high
setting. The chromatin was sheared to an average length of 200–600 bp and subjected to
immunoprecipitation using IgG as a negative control or with specific antibodies against
H3K27Ac, H3K4me3, H3K9Ac. ChIP-Sequencing was performed in an Illumina NovaSeq
6000 sequencing machine (Illumina, San Diego, CA, USA) at a 100-base, paired-end read
resolution. After read quality assessment and adapter trimming, the sequenced reads were
mapped to the mouse genome (mm10) using the Bowtie2 software. Sequencing produced
between 26 and 45 million reads per sample, of which 80% to 96% mapped to the reference
genome. Significantly enriched ChIP regions (relative to the corresponding input sample)
were detected using the model-based analysis of ChIP-Seq (MACS) software.
4.13. Lgr5 Promoter Activity Reporter Assay
HEK293 cells were co-transfected in 12 well plates with an Lgr5 promoter–reporter
construct and secreted alkaline phosphatase (SEAP) plasmid as normalization control
constructs using lipofectamine 2000. After 16 h, fresh media was added along with 1, 5 and
10 mM of sodium butyrate. A total of 50 µL of media was collected after 24 h and luciferase
assay was performed using Gaussia Luciferase Assay kit (GeneCopoeia) according to the
manufacturer’s instructions.
4.14. Cellular Thermal Shift Assay (CETSA) and Western Blotting
Intact, viable SW480 cells that express high levels of Lgr5, grown to 70–80% confluency,
were harvested and resuspended to a final concentration of 20 × 106 cells/mL in the plain
medium. Cells were divided into different tubes and treated with either water or different
concentrations of sodium butyrate followed by incubation at 37 ◦ C for 4 h. A total of
100 L of cell suspension was aliquoted into the PCR plate and heated at temperatures
ranging from 43 to 64 ◦ C for 3 min. The plates were then snap-frozen in liquid nitrogen
followed by incubation in a water bath three times. All samples were then treated with
4X Laemmeli buffer, boiled, and loaded on SDS-PAGE gel, transferred to a nitrocellulose
membrane, and incubated with Lgr5 antibody. Protein levels on Western blot were pictured
on ChemiDoc and analyzed by ImageJ software. Densitometry analysis was performed
and graphs were drawn.
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4.15. Molecular Docking
Autodock Vina software program was used for molecular docking [78]. The crystal structure of LGR5 (PDB ID: 4UFR) [79] was downloaded from the protein data bank.
Autodock Vina is known for high performance and accuracy for structure-based virtual
screening to aid drug discovery. It is freely available software from The Scripps Research
Institute (http://vina.scripps.edu/, accessed on 9 November 2021). The 3D-grid box covering all active and crucial residues is generated and assessed by software using established
multiple algorithms to predict favorable binding poses. For the present study, a 3D-grid
box with a grid center coordinate consisting of grid spacing 1.0 A0 and 60 × 60 × 60 point
size was generated, and default parameters of the Autodock tools were used. Both protein
and Butyrate were prepared by adding polar hydrogens and total Kollman and Gasteiger
charges. Lamarckian GA was used for the prediction of the top 10 conformations. Next, the
most stable conformation based of low binding energy, hydrogen bonds, and bond distance
were selected and visualized with Pymol (https://pymol.org/2/, accessed on 9 November
2021) [80].
4.16. RNA Sequencing
RNA seq was carried out on cultured young adult mouse colon cells (YAMCs) maintained in vitro as previously described [77]. The cells were infected only with CR for 3 h
or infected with CR for 3 h then treated with 5mM sodium butyrate (Sigma) for 24 h.
Non-infected YAMC cells were used as control. RNA was isolated from the cells using
TRIzol (Ambion Life Technologies, Austin, TX, USA) and converted to cDNA using the
High-Capacity cDNA Reverse Transcription kit (Applied Biosystems, Waltham, MA, USA).
The concentration of RNA was measured using a spectrophotometer (Nanodrop 2000,
Thermo Fisher Scientific). About two µg of total RNA for each sample was sent to the
genome sequencing facility (University of Kansas Medical Centre, KS) for RNA sequencing.
The procedure for RNA sequencing and analysis has been described previously [81]. Briefly,
after RNA isolation, subsets of RNA become isolated for polyA transcripts, whereupon they
are then converted to cDNA. This is followed by the addition of sequencing adaptors to the
ends of the cDNA fragments before amplification by PCR to generate the RNA-sequencing
library, which is proceeded by downstream transcriptome analysis. YAMC–control, YAMC–
Citrobacter rodentium, and YAMC–Citrobacter rodentium + sodium butyrate samples were
sequenced in biological triplicates. Sequencing was generated between 25.1 and 28.6 million reads per sample. The read quality was assessed using the FastQC software. The
reads were then mapped to the mouse genome (GRCm38. rel98) using the STAR software,
version 2.3.1z. Between 97% and 98% of the sequenced reads were mapped to the reference
genomes in the 9 samples, resulting in between 24.6 and 28.0 million mapped reads per
sample, of which, on average, 92.5% were uniquely mapped reads. Transcript abundance
estimates were calculated using the featureCounts software. Expression normalization and
differential gene expression calculations were performed in DESeq2 software to identify
statistically significant, differentially expressed genes.
4.17. Statistical Analysis
The values are expressed as mean ± SD. Statistical analyses of all studies were
performed using unpaired, two-sided Student’s t-tests or one-way analysis of variance
(ANOVA) models for multiple-group comparisons. p < 0.05 was considered statistically
significant. The sample size was determined based on the results from pilot studies with
similar mouse numbers. All experiments used n = 5 mice per group unless otherwise
indicated and represent 2–3 independent experiments. For in vivo studies, the reported
sample number per experiment represents biologic replicates (comparing animals of one
genotype with littermates of another genotype). Both male and female mice were used in
the study. All analyses were performed using GraphPad, version 9.
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5. Conclusions
In conclusion, this study delineates the ability of Pectin and Tributyrin diets to alleviate
colitis through microbiome and mucin restoration, Lgr5+ cell expansion, and reduced
expression of proinflammatory markers. This work highlights the crosstalk between diet,
microbiota, and the colon stem cells working together to help restore the crypt structure
following an insult.
Supplementary Materials: The following are available online at https://www.mdpi.com/article/
10.3390/ijms23010339/s1.
Author Contributions: I.A. and K.Y. contributed equally and share first co-authorship. I.A.: Study
design, acquisition, analysis and interpretation of the data, manuscript writing; K.Y., B.C.R.: acquisition, analysis and interpretation of the data, manuscript writing; J.S.: Intellectual discussion
and interpretation; S.A.: Intellectual discussion and interpretation; V.S.: Intellectual discussion and
interpretation; T.M.A.: Intellectual discussion and interpretation; S.U.: Study design, supervision,
interpretation, intellectual discussion and funding. All authors have read and agreed to the published
version of the manuscript.
Funding: This study was funded by an R01 (R01CA185322) from the National Cancer Institute and
start-up funds from the University of Kansas Cancer Center.
Institutional Review Board Statement: Not applicable.
Informed Consent Statement: Not applicable.
Data Availability Statement: All the data are contained within the manuscript. For the 16S gene sequencing, the raw sequence files (.fastq.gz) were submitted to the NCBI Sequence Read Archive (SRA)
database and can be accessed here: https://www.ncbi.nlm.nih.gov/sra/PRJNA757697, accessed on 9
November 2021.
Acknowledgments: We would like to acknowledge Holly Zink, Medical Writer, Department of
Surgery, University of Kansas Medical Center, for help with professional writing and formatting.
Conflicts of Interest: The authors declare no conflict of interest.

References
1.
2.
3.
4.
5.

6.
7.

8.
9.
10.
11.

Sommer, F.; Bäckhed, F. The gut microbiota—Masters of host development and physiology. Nat. Rev. Microbiol. 2013, 11, 227–238.
[CrossRef]
Khor, B.; Gardet, A.; Xavier, R.J. Genetics and pathogenesis of inflammatory bowel disease. Nat. Cell Biol. 2011, 474, 307–317.
[CrossRef]
Xing, P.Y.; Pettersson, S.; Kundu, P. Microbial Metabolites and Intestinal Stem Cells Tune Intestinal Homeostasis. Proteomics 2020,
20, e1800419. [CrossRef]
Yatsunenko, T.; Rey, F.E.; Manary, M.J.; Trehan, I.; Dominguez-Bello, M.G.; Contreras, M.; Magris, M.; Hidalgo, G.; Baldassano,
R.N.; Anokhin, A.P.; et al. Human gut microbiome viewed across age and geography. Nature 2012, 486, 222–227. [CrossRef]
Candela, M.; Perna, F.; Carnevali, P.; Vitali, B.; Ciati, R.; Gionchetti, P.; Rizzello, F.; Campieri, M.; Brigidi, P. Interaction of
probiotic Lactobacillus and Bifidobacterium strains with human intestinal epithelial cells: Adhesion properties, competition
against enteropathogens and modulation of IL-8 production. Int. J. Food Microbiol. 2008, 125, 286–292. [CrossRef]
Panasevich, M.R.; Allen, J.M.; A Wallig, M.; A Woods, J.; Dilger, R.N. Moderately Fermentable Potato Fiber Attenuates Signs and
Inflammation Associated with Experimental Colitis in Mice. J. Nutr. 2015, 145, 2781–2788. [CrossRef]
Frank, D.N.; St Amand, A.L.; Feldman, R.A.; Boedeker, E.C.; Harpaz, N.; Pace, N.R. Molecular-phylogenetic characterization of
microbial community imbalances in human inflammatory bowel diseases. Proc. Natl. Acad. Sci. USA 2007, 104, 13780–13785.
[CrossRef]
Bäckhed, F.; Ley, R.E.; Sonnenburg, J.L.; Peterson, D.A.; Gordon, J.I. Host-Bacterial Mutualism in the Human Intestine. Science
2005, 307, 1915–1920. [CrossRef]
Robosky, L.C.; Wells, D.F.; Egnash, L.A.; Manning, M.L.; Reily, M.D.; Robertson, D.G. Metabonomic Identification of Two Distinct
Phenotypes in Sprague-Dawley (Crl:CD(SD)) Rats. Toxicol. Sci. 2005, 87, 277–284. [CrossRef]
Turnbaugh, P.J.; Ley, R.E.; Mahowald, M.A.; Magrini, V.; Mardis, E.R.; Gordon, J.I. An obesity-associated gut microbiome with
increased capacity for energy harvest. Nature 2006, 444, 1027–1031. [CrossRef]
Rohde, C.M.; Wells, D.F.; Robosky, L.C.; Manning, M.L.; Clifford, C.B.; Reily, M.; Robertson, D.G. Metabonomic Evaluation of
Schaedler Altered Microflora Rats. Chem. Res. Toxicol. 2007, 20, 1388–1392. [CrossRef]

Int. J. Mol. Sci. 2022, 23, 339

12.
13.
14.
15.
16.
17.
18.
19.
20.
21.

22.
23.

24.
25.

26.
27.
28.
29.

30.
31.

32.

33.
34.
35.
36.
37.

38.

23 of 25

Hibbing, M.E.; Fuqua, C.; Parsek, M.R.; Peterson, S.B. Bacterial competition: Surviving and thriving in the microbial jungle. Nat.
Rev. Microbiol. 2010, 8, 15–25. [CrossRef]
Natividad, J.M.M.; Verdu, E.F. Modulation of intestinal barrier by intestinal microbiota: Pathological and therapeutic implications.
Pharmacol. Res. 2013, 69, 42–51. [CrossRef]
Umar, S. Intestinal Stem Cells. Curr. Gastroenterol. Rep. 2010, 12, 340–348. [CrossRef]
Barker, N.; Van Es, J.H.; Kuipers, J.; Kujala, P.; Van Den Born, M.; Cozijnsen, M.; Haegebarth, A.; Korving, J.; Begthel, H.; Peters,
P.J.; et al. Identification of stem cells in small intestine and colon by marker gene Lgr5. Nature 2007, 449, 1003–1007. [CrossRef]
Carmon, K.; Gong, X.; Lin, Q.; Thomas, A.; Liu, Q. R-spondins function as ligands of the orphan receptors LGR4 and LGR5 to
regulate Wnt/ -catenin signaling. Proc. Natl. Acad. Sci. USA 2011, 108, 11452–11457. [CrossRef]
Barker, N.; Tan, S.; Clevers, H. Lgr proteins in epithelial stem cell biology. Development 2013, 140, 2484–2494. [CrossRef]
Farin, H.F.; Van Es, J.H.; Clevers, H. Redundant Sources of Wnt Regulate Intestinal Stem Cells and Promote Formation of Paneth
Cells. Gastroenterology 2012, 143, 1518–1529.e7. [CrossRef]
Kabiri, Z.; Greicius, G.; Madan, B.; Biechele, S.; Zhong, Z.; Zaribafzadeh, H.; Edison; Aliyev, J.; Wu, Y.; Bunte, R.; et al. Stroma
provides an intestinal stem cell niche in the absence of epithelial Wnts. Development 2014, 141, 2206–2215. [CrossRef]
Pinto, D.; Gregorieff, A.; Begthel, H.; Clevers, H. Canonical Wnt signals are essential for homeostasis of the intestinal epithelium.
Genes Dev. 2003, 17, 1709–1713. [CrossRef]
Higgins, L.; Frankel, G.; Douce, G.; Dougan, G.; MacDonald, T.T. Citrobacter rodentium Infection in Mice Elicits a Mucosal Th1
Cytokine Response and Lesions Similar to Those in Murine Inflammatory Bowel Disease. Infect. Immun. 1999, 67, 3031–3039.
[CrossRef]
Mundy, R.; MacDonald, T.T.; Dougan, G.; Frankel, G.; Wiles, S. Citrobacter rodentium of mice and man. Cell. Microbiol. 2005, 7,
1697–1706. [CrossRef]
Chandrakesan, P.; Roy, B.C.; Jakkula, L.U.M.R.; Ahmed, I.; Ramamoorthy, P.; Tawfik, O.; Papineni, R.; Houchen, C.W.; Anant, S.;
Umar, S. Utility of a bacterial infection model to study epithelial–mesenchymal transition, mesenchymal–epithelial transition or
tumorigenesis. Oncogene 2014, 33, 2639–2654. [CrossRef]
Collins, J.W.; Keeney, K.M.; Crepin, V.F.; Rathinam, V.A.K.; Fitzgerald, K.; Finlay, B.B.; Frankel, G. Citrobacter rodentium: Infection,
inflammation and the microbiota. Nat. Rev. Genet. 2014, 12, 612–623. [CrossRef]
Pickard, J.M.; Maurice, C.F.; Kinnebrew, M.A.; Abt, M.C.; Schenten, D.; Golovkina, T.V.; Bogatyrev, S.R.; Ismagilov, R.F.; Pamer,
E.G.; Turnbaugh, P.; et al. Rapid fucosylation of intestinal epithelium sustains host–commensal symbiosis in sickness. Nat. Cell
Biol. 2014, 514, 638–641. [CrossRef]
Beukema, M.; Faas, M.M.; de Vos, P. The effects of different dietary fiber pectin structures on the gastrointestinal immune barrier:
Impact via gut microbiota and direct effects on immune cells. Exp. Mol. Med. 2020, 52, 1364–1376. [CrossRef]
Muniz, L.R.; Knosp, C.; Yeretssian, G. Intestinal antimicrobial peptides during homeostasis, infection, and disease. Front. Immunol.
2012, 3, 310. [CrossRef]
Peterson, L.W.; Artis, D. Intestinal epithelial cells: Regulators of barrier function and immune homeostasis. Nat. Rev. Immunol.
2014, 14, 141–153. [CrossRef]
Bergstrom, K.S.B.; Kissoon-Singh, V.; Gibson, D.L.; Ma, C.; Montero, M.; Sham, H.P.; Ryz, N.; Huang, T.; Velcich, A.; Finlay, B.B.;
et al. Muc2 Protects against Lethal Infectious Colitis by Disassociating Pathogenic and Commensal Bacteria from the Colonic
Mucosa. PLoS Pathog. 2010, 6, e1000902. [CrossRef]
Grondin, J.A.; Kwon, Y.H.; Far, P.M.; Haq, S.; Khan, W.I. Mucins in Intestinal Mucosal Defense and Inflammation: Learning from
Clinical and Experimental Studies. Front. Immunol. 2020, 11, 2054. [CrossRef]
Hopkins, E.G.D.; Roumeliotis, T.I.; Mullineaux-Sanders, C.; Choudhary, J.S.; Frankel, G. Intestinal Epithelial Cells and the
Microbiome Undergo Swift Reprogramming at the Inception of Colonic Citrobacter rodentium Infection. mBio 2019, 10, e00062-19.
[CrossRef]
Macia, L.; Tan, J.; Vieira, A.T.; Leach, K.; Stanley, D.; Luong, S.; Maruya, M.; lan McKenzie, C.; Hijikata, A.; Wong, C.; et al.
Metabolite-sensing receptors GPR43 and GPR109A facilitate dietary fibre-induced gut homeostasis through regulation of the
inflammasome. Nat. Commun. 2015, 6, 6734. [CrossRef]
Yi, J.; Bergstrom, K.; Fu, J.; Shan, X.; McDaniel, J.M.; McGee, S.; Qu, D.; Houchen, C.W.; Liu, X.; Xia, L. Dclk1 in tuft cells promotes
inflammation-driven epithelial restitution and mitigates chronic colitis. Cell Death Differ. 2019, 26, 1656–1669. [CrossRef]
Shi, Y.; Shu, B.; Yang, R.; Xu, Y.; Xing, B.; Liu, J.; Chen, L.; Qi, S.; Liu, X.; Wang, P.; et al. Wnt and Notch signaling pathway
involved in wound healing by targeting c-Myc and Hes1 separately. Stem Cell Res. Ther. 2015, 6, 120. [CrossRef]
Lawrence, M.; Daujat, S.; Schneider, R. Lateral Thinking: How Histone Modifications Regulate Gene Expression. Trends Genet.
2016, 32, 42–56. [CrossRef]
Satoh, J.-I.; Obayashi, S.; Tabunoki, H.; Wakana, T.; Kim, S.U. Stable Expression of Neurogenin 1 Induces LGR5, a Novel Stem Cell
Marker, in an Immortalized Human Neural Stem Cell Line HB1.F3. Cell. Mol. Neurobiol. 2009, 30, 415–426. [CrossRef]
de Lau, W.; Kujala, P.; Schneeberger, K.; Middendorp, S.; Li, V.S.W.; Barker, N.; Martens, A.; Hofhuis, F.; DeKoter, R.; Peters, P.J.;
et al. Peyer’s Patch M Cells Derived from Lgr5 + Stem Cells Require SpiB and Are Induced by RankL in Cultured “Miniguts”.
Mol. Cell. Biol. 2012, 32, 3639–3647. [CrossRef]
Sasaki, I.; Hoshino, K.; Sugiyama, T.; Yamazaki, C.; Yano, T.; Iizuka, A.; Hemmi, H.; Tanaka, T.; Saito, M.; Sugiyama, M.; et al.
Spi-B is critical for plasmacytoid dendritic cell function and development. Blood 2012, 120, 4733–4743. [CrossRef]

Int. J. Mol. Sci. 2022, 23, 339

39.
40.
41.
42.

43.
44.
45.
46.
47.
48.
49.
50.
51.

52.
53.

54.

55.
56.
57.
58.

59.
60.
61.
62.
63.
64.
65.

66.

24 of 25

Kobayashi, T.; Siegmund, B.; Le Berre, C.; Wei, S.C.; Ferrante, M.; Shen, B.; Bernstein, C.N.; Danese, S.; Peyrin-Biroulet, L.; Hibi, T.
Ulcerative colitis. Nat. Rev. Dis. Prim. 2020, 6, 1–20. [CrossRef]
Luperchio, S.A.; Schauer, D.B. Molecular pathogenesis of Citrobacter rodentium and transmissible murine colonic hyperplasia.
Microbes Infect. 2001, 3, 333–340. [CrossRef]
Ahmed, I.; Chandrakesan, P.; Tawfik, O.; Xia, L.; Anant, S.; Umar, S. Critical Roles of Notch and Wnt/β-Catenin Pathways in the
Regulation of Hyperplasia and/or Colitis in Response to Bacterial Infection. Infect. Immun. 2012, 80, 3107–3121. [CrossRef]
Lupp, C.; Robertson, M.L.; Wickham, M.; Sekirov, I.; Champion, O.L.; Gaynor, E.C.; Finlay, B.B. Host-Mediated Inflammation
Disrupts the Intestinal Microbiota and Promotes the Overgrowth of Enterobacteriaceae. Cell Host Microbe 2007, 2, 119–129.
[CrossRef]
Liu, Z.; Zaki, H.; Vogel, P.; Gurung, P.; Finlay, B.B.; Deng, W.; Lamkanfi, M.; Kanneganti, T.-D. Role of Inflammasomes in Host
Defense against Citrobacter rodentium Infection. J. Biol. Chem. 2012, 287, 16955–16964. [CrossRef]
Maukonen, J.; Saarela, M. Human gut microbiota: Does diet matter? Proc. Nutr. Soc. 2014, 74, 23–36. [CrossRef]
Wu, G.D.; Bushmanc, F.D.; Lewis, J.D. Diet, the human gut microbiota, and IBD. Anaerobe 2013, 24, 117–120. [CrossRef]
Rothe, M.; Blaut, M. Evolution of the gut microbiota and the influence of diet. Benef. Microbes 2013, 4, 31–37. [CrossRef]
Scott, K.P.; Gratz, S.W.; Sheridan, P.O.; Flint, H.J.; Duncan, S.H. The influence of diet on the gut microbiota. Pharmacol. Res. 2013,
69, 52–60. [CrossRef]
Wong Gut Microbiota, Diet, and Heart Disease. J. AOAC Int. 2012, 95, 24–30. [CrossRef]
Brown, K.; DeCoffe, D.; Molcan, E.; Gibson, D.L. Diet-Induced Dysbiosis of the Intestinal Microbiota and the Effects on Immunity
and Disease. Nutrients 2012, 4, 1095–1119. [CrossRef]
Clarke, S.; Murphy, E.F.; Nilaweera, K.; Ross, R.; Shanahan, F.; O’Toole, P.W.; Cotter, P.D. The gut microbiota and its relationship
to diet and obesity. Gut Microbes 2012, 3, 186–202. [CrossRef]
Png, C.W.; Lindén, S.K.; Gilshenan, K.S.; Zoetendal, E.G.; McSweeney, C.S.; I Sly, L.; McGuckin, M.; Florin, T.H.J. Mucolytic
Bacteria With Increased Prevalence in IBD Mucosa Augment In Vitro Utilization of Mucin by Other Bacteria. Am. J. Gastroenterol.
2010, 105, 2420–2428. [CrossRef]
Jin, S.; Zhao, D.; Cai, C.; Song, D.; Shen, J.; Xu, A.; Qiao, Y.; Ran, Z.; Zheng, Q. Low-dose penicillin exposure in early life decreases
Th17 and the susceptibility to DSS colitis in mice through gut microbiota modification. Sci. Rep. 2017, 7, srep43662. [CrossRef]
Qu, D.; Weygant, N.; May, R.; Chandrakesan, P.; Madhoun, M.; Ali, N.; Sureban, S.M.; An, G.; Schlosser, M.J.; Houchen, C.W.
Ablation of Doublecortin-Like Kinase 1 in the Colonic Epithelium Exacerbates Dextran Sulfate Sodium-Induced Colitis. PLoS
ONE 2015, 10, e0134212. [CrossRef]
Watanabe, T.; Asano, N.; Murray, P.J.; Ozato, K.; Tailor, P.; Fuss, I.J.; Kitani, A.; Strober, W. Muramyl dipeptide activation of
nucleotide-binding oligomerization domain 2 protects mice from experimental colitis. J. Clin. Investig. 2008, 118, 545–559.
[CrossRef]
Yamamoto-Furusho, J.K.; Sanchez-Muñoz, F.; Dominguez-Lopez, A. Role of cytokines in inflammatory bowel disease. World J.
Gastroenterol. 2008, 14, 4280–4288. [CrossRef]
Groβ, P.; Doser, K.; Falk, W.; Obermeier, F.; Hofmann, C. IL-33 attenuates development and perpetuation of chronic intestinal
inflammation. Inflamm. Bowel Dis. 2012, 18, 1900–1909. [CrossRef]
Pu, Z.; Che, Y.; Zhang, W.; Sun, H.; Meng, T.; Xie, H.; Cao, L.; Hao, H. Dual roles of IL-18 in colitis through regulation of the
function and quantity of goblet cells. Int. J. Mol. Med. 2019, 43, 2291–2302. [CrossRef]
Jayme, T.S.; Leung, G.; Wang, A.; Workentine, M.L.; Rajeev, S.; Shute, A.; E Callejas, B.; Mancini, N.; Beck, P.L.; Panaccione, R.;
et al. Human interleukin-4-treated regulatory macrophages promote epithelial wound healing and reduce colitis in a mouse
model. Sci. Adv. 2020, 6, eaba4376. [CrossRef]
Gross, V.; Andus, T.; Caesar, I.; Roth, M.; Schölmerich, J. Evidence for continuous stimulation of interleukin-6 production in
Crohn’s disease. Gastroenterology 1992, 102, 514–519. [CrossRef]
Atreya, R.; Neurath, M.F. Involvement of IL-6 in the Pathogenesis of Inflammatory Bowel Disease and Colon Cancer. Clin. Rev.
Allergy Immunol. 2005, 28, 187–196. [CrossRef]
Waldner, M.J.; Neurath, M.F. Master regulator of intestinal disease: IL-6 in chronic inflammation and cancer development. Semin.
Immunol. 2014, 26, 75–79. [CrossRef]
Moparthi, L.; Koch, S. Wnt signaling in intestinal inflammation. Differentiation 2019, 108, 24–32. [CrossRef] [PubMed]
Haegebarth, A.; Clevers, H. Wnt Signaling, Lgr5, and Stem Cells in the Intestine and Skin. Am. J. Pathol. 2009, 174, 715–721.
[CrossRef]
Davidson, L.A.; Goldsby, J.S.; Callaway, E.S.; Shah, M.S.; Barker, N.; Chapkin, R.S. Alteration of colonic stem cell gene signatures
during the regenerative response to injury. Biochim. Biophys. Acta Mol. Basis Dis. 2012, 1822, 1600–1607. [CrossRef]
Yui, S.; Nakamura, T.; Sato, T.; Nemoto, Y.; Mizutani, T.; Zheng, X.; Ichinose, S.; Nagaishi, T.; Okamoto, R.; Tsuchiya, K.; et al.
Functional engraftment of colon epithelium expanded in vitro from a single adult Lgr5+ stem cell. Nat. Med. 2012, 18, 618–623.
[CrossRef]
Lee, Y.-S.; Kim, T.-Y.; Kim, Y.; Lee, S.-H.; Kim, S.; Kang, S.W.; Yang, J.-Y.; Baek, I.-J.; Sung, Y.H.; Park, Y.-Y.; et al. Microbiota-Derived
Lactate Accelerates Intestinal Stem-Cell-Mediated Epithelial Development. Cell Host Microbe 2018, 24, 833–846.e6. [CrossRef]

Int. J. Mol. Sci. 2022, 23, 339

67.

68.

69.
70.

71.
72.

73.

74.

75.

76.
77.
78.
79.
80.

81.

25 of 25

Levy, A.; Stedman, A.; Deutsch, E.; Donnadieu, F.; Virgin, H.W.; Sansonetti, P.J.; Nigro, G. Innate immune receptor NOD2
mediates LGR5+ intestinal stem cell protection against ROS cytotoxicity via mitophagy stimulation. Proc. Natl. Acad. Sci. USA
2020, 117, 1994–2003. [CrossRef] [PubMed]
Gaschott, T.; Steinhilber, D.; Milovic, V.; Stein, J. Tributyrin, a stable and rapidly absorbed prodrug of butyric acid, enhances
antiproliferative effects of dihydroxycholecalciferol in human colon cancer cells. J. Nutr. 2001, 131, 1839–1843. [CrossRef]
[PubMed]
Kaiko, G.E.; Ryu, S.H.; Koues, O.I.; Collins, P.L.; Solnica-Krezel, L.; Pearce, E.J.; Pearce, E.L.; Oltz, E.M.; Stappenbeck, T.S. The
Colonic Crypt Protects Stem Cells from Microbiota-Derived Metabolites. Cell 2016, 167, 1137. [CrossRef]
Chandrakesan, P.; Ahmed, I.; Chinthalapally, A.; Singh, P.; Awasthi, S.; Anant, S.; Umar, S. Distinct Compartmentalization of
NF-κB Activity in Crypt and Crypt-Denuded Lamina Propria Precedes and Accompanies Hyperplasia and/or Colitis following
Bacterial Infection. Infect. Immun. 2011, 80, 753–767. [CrossRef]
Wang, Y.; Xiang, G.-S.; Kourouma, F.; Umar, S. Citrobacter rodentium -induced NF-κ B activation in hyperproliferating colonic
epithelia: Role of p65 (Ser536 ) phosphorylation. Br. J. Pharmacol. 2006, 148, 814–824. [CrossRef]
Ahmed, I.; Roy, B.C.; Jakkula, L.U.M.R.; Subramaniam, D.; Dandawate, P.; Anant, S.; Sampath, V.; Umar, S. Infection-induced
signals generated at the plasma membrane epigenetically regulate Wnt signaling in vitro and in vivo. J. Biol. Chem. 2020, 295,
1021–1035. [CrossRef]
Caporaso, J.G.; Lauber, C.L.; Walters, W.A.; Berg-Lyons, D.; Huntley, J.; Fierer, N.; Owens, S.M.; Betley, J.; Fraser, L.; Bauer,
M.; et al. Ultra-high-throughput microbial community analysis on the Illumina HiSeq and MiSeq platforms. ISME J. 2012, 6,
1621–1624. [CrossRef]
Caporaso, J.G.; Kuczynski, J.; Stombaugh, J.; Bittinger, K.; Bushman, F.D.; Costello, E.K.; Fierer, N.; Peña, A.G.; Goodrich, J.K.;
Gordon, J.I.; et al. QIIME allows analysis of high-throughput community sequencing data. Nat. Methods 2010, 7, 335–336.
[CrossRef]
Langille, M.G.I.; Zaneveld, J.; Caporaso, J.G.; McDonald, D.; Knights, D.; Reyes, J.A.; Clemente, J.C.; Burkepile, D.E.; Thurber,
R.L.V.; Knight, R.; et al. Predictive functional profiling of microbial communities using 16S rRNA marker gene sequences. Nat.
Biotechnol. 2013, 31, 814–821. [CrossRef] [PubMed]
Napolitano, L.M.; Koruda, M.J.; Meyer, A.A.; Baker, C.C. The Impact of Femur Fracture with Associated Soft Tissue Injury on
Immune Function and Intestinal Permeability. Shock 1996, 5, 202–207. [CrossRef] [PubMed]
Chandrakesan, P.; Ahmed, I.; Anwar, T.; Wang, Y.; Sarkar, S.; Singh, P.; Peleg, S.; Umar, S. Novel Changes in NF-κB Activity
during Progression and Regression Phases of Hyperplasia. J. Biol. Chem. 2010, 285, 33485–33498. [CrossRef]
Trott, O.; Olson, A.J. AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient
optimization, and multithreading. J. Comput. Chem. 2010, 31, 455–461. [CrossRef] [PubMed]
Peng, W.C.; de Lau, W.; Forneris, F.; Granneman, J.C.; Huch, M.; Clevers, H.; Gros, P. Structure of Stem Cell Growth Factor
R-spondin 1 in Complex with the Ectodomain of Its Receptor LGR5. Cell Rep. 2013, 3, 1885–1892. [CrossRef]
Alexander, N.; Woetzel, N.; Meiler, J. Bcl::Cluster: A method for clustering biological molecules coupled with visualization in the
Pymol Molecular Graphics System. In Proceedings of the 2011 IEEE 1st International Conference on Computational Advances in
Bio and Medical Sciences (ICCABS), Orlando, FL, USA, 3–5 February 2011; pp. 13–18.
Kukurba, K.R.; Montgomery, S.B. RNA Sequencing and Analysis. Cold Spring Harb. Protoc. 2015, 2015, 951–969. [CrossRef]

